Global Startups Insights
Lets your startup
California, Funding News, USA Startup Funding News

Tesorai Raises $5.3 Million Seed Funding to Advance AI-Powered Life Sciences Research

November 18, 2026
By
Loren Baker
Tesorai Raises $5.3 Million Seed Funding to Advance AI-Powered Life Sciences Research

Tesorai, a San Diego-based artificial intelligence company developing tools for life sciences research, has raised $5.3 million in seed funding. The round included investment from Perplexity Fund, IQT, South Central Ventures, New Stack Ventures, NextGen Venture Partners, f7 Ventures, VitalStage Ventures, and ZAKA.

The latest funding brings Tesorai’s total funding to $8 million.

The company plans to use the capital to expand its work with biopharmaceutical companies and research organizations, build partnerships with life sciences technology providers and extend its platform beyond protein analysis to other types of molecular data.

“Life science R&D is accelerating and becoming increasingly autonomous, which makes it more important to extract as much insight as possible from every experiment,” said Charlie Kim, co-founder and chief scientific officer of Tesorai. “Tesorai does this for a lab’s new data and for thousands of published studies. The gains compound as each experiment builds on the last, and ultimately, this helps the industry develop better medicines faster.”

Tesorai builds tools powered by AI to help scientists go through raw experimental data from novel studies and past research. Their platform was developed to help researchers uncover scientific facts that may have been overlooked in the previous analyses.

Many scientific data are stored at public repositories, research institutes, and private databases. The variation in the procedures for conducting and recording research makes it hard for researchers to compare their results with the data obtained in other studies.

Tesorai addresses this challenge interpreting raw experimental findings and not just the published results. They standardized raw data information from various experiments ensuring easy access to the results.

This firm offers three main products in its suite: Tesorai Search which can process raw molecular data; Tesorai Chat where scientists can interactively analyze data by using chat prompts; and Tesorai Trove which is a collection of organized research databases.

According to the company, its technology has processed thousands of files containing terabytes of experimental data within hours, compared with traditional workflows that could take months.

Tesorai recently demonstrated its approach through an analysis of existing Alzheimer’s disease research. In August 2026, its researchers reprocessed raw data from five publicly available brain studies and identified phosphorylated tau 217 (p-tau217), an Alzheimer’s disease biomarker that had not been reported in the original studies.

In a research preprint publication, Tesorai revealed the results of its research. However, the results have not yet been peer-reviewed.

Besides, Tesorai is also investigating how its analyzed data could be beneficial to AI systems used in the field of biological research. In a different preprint published in August, its researchers concluded that using protein information can improve the results of a small scale single-cell AI model to such an extent that it shows equal or even better results than models trained only on RNA data. The comparison model was 40 times bigger than the one from the study.

Tesorai was founded by Miao, Cimermancic, and Kim, who previously worked together at Verily, Alphabet’s life sciences company. The founding team brings experience in molecular science, business development, strategic partnerships, and AI.

Since its earlier pre-seed financing, the company has signed contracts with biopharmaceutical and research organizations and collaborated with institutions including MD Anderson Cancer Center, New York University, and the Michael J. Fox Foundation. It has also received its first U.S. patent covering one of its AI models.

With the new funding, Tesorai plans to expand its research dataset catalog and provide processed molecular data to organizations developing AI models for biological applications. Its longer-term goal is to support more types of molecular data and a wider range of scientific research workflows.

Recommended Stories for You